‘Absolutely staggering’: Results from experimental drug trial to prevent Parkinson’s disease
For the first time, the Australian-led trial has found evidence that an experimental drug could lessen inflammation in the brains of people at high risk of Parkinson’s, potentially slowing or even stopping its development.
Read original article on Brisbane Times - Latest News →